Citation: Hs. Inaloz et al., Recurrent intravascular papillary endothelial hyperplasia developing from a pyogenic granuloma, J EUR A D V, 15(2), 2001, pp. 156-158
Authors:
Green, D
Elgendy, S
Patel, G
Skordalakes, E
Goodwin, CA
Scully, MF
Kakkar, VV
Deadman, JJ
Citation: D. Green et al., Substrate related O,O-dialkyldipeptidyl Psi carboxybenzylphosphonates, a new type of thrombin inhibitor, PHOSPHOR SU, 156, 2000, pp. 151-155
Authors:
Mukherjee, M
Ranlall, N
Patel, G
Rutlin, A
Jehanli, A
Kakkar, VV
Citation: M. Mukherjee et al., Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease, BL COAG FIB, 11(3), 2000, pp. 285-291
Authors:
El-Daher, SS
Patel, Y
Siddiqua, A
Hassock, S
Edmunds, S
Maddison, B
Patel, G
Goulding, D
Lupu, F
Wojcikiewicz, RJH
Authi, KS
Citation: Ss. El-daher et al., Distinct localization and function of (IP3)-I-1,4,5 receptor subtypes and the (IP4)-I-1,3,4,5 receptor GAP1(IP4BP) in highly purified human platelet membranes, BLOOD, 95(11), 2000, pp. 3412-3422
Authors:
Patel, G
Husman, W
Jehanli, AM
Deadman, JJ
Green, D
Kakkar, VV
Brennand, DM
Citation: G. Patel et al., A cyclic peptide analogue of the loop III region of platelet-derived growth factor-BB is a synthetic antigen for the native protein, J PEPT RES, 53(1), 1999, pp. 68-74